Author:
Badia Eric,Duchesne Marie-Josephe,Nicolas Jean-Claude,Pons Michel
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Cole MP, Jones CT, Todd ID: A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI 46474. Br J Cancer 25: 270–275, 1971
2. Furr BJ, Patterson JS, Richardson DN, Slater SR, Wakeling AE: Tamoxifen. In: Goldberg ME (ed) Pharmacological and Biochemical Properties of Drug Substances. Vol 2. American Pharmaceutical Association, Washington, 1979, pp 355–399
3. Wolf DM, Jordan VC: The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variants contains a point mutation in the ligand binding domain. Breast Cancer Res Treat 31: 129–138, 1994
4. Zhang Q-X, Borg A, Fuqua SAW: An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Cancer Res 53: 5882–5884, 1993
5. Osborne CK, Coronado E, Allred DC, Wiebe V, De Gregorio M: Acquired tamoxifen resistance: correlation with reduced tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. J Natl Cancer Inst 83: 1477–1482, 1991
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献